Download innovation and marketing in the pharmaceutical industry emerging practices research and policies 20 international series in quantitative marketing in pdf or read innovation and marketing in the pharmaceutical industry emerging practices research and policies 20 international series in quantitative marketing in pdf online books in PDF, EPUB and Mobi Format. Click Download or Read Online button to get innovation and marketing in the pharmaceutical industry emerging practices research and policies 20 international series in quantitative marketing in pdf book now. This site is like a library, Use search box in the widget to get ebook that you want.



Innovation And Marketing In The Pharmaceutical Industry

Author: Min Ding
Publisher: Springer Science & Business Media
ISBN: 1461478014
Size: 55.65 MB
Format: PDF, Kindle
View: 2122
Download and Read
The pharmaceutical industry is one of today’s most dynamic and complex industries, involving commercialization of cutting-edge scientific research, a huge web of stakeholders (from investors to doctors), multi-stage supply chains, fierce competition in the race to market, and a challenging regulatory environment. The stakes are high, with each new product raising the prospect of spectacular success—or failure. Worldwide revenues are approaching $1 trillion; in the U.S. alone, marketing for pharmaceutical products is, itself, a multi-billion dollar industry. In this volume, the editors showcase contributions from experts around the world to capture the state of the art in research, analysis, and practice, and covering the full spectrum of topics relating to innovation and marketing, including R&D, promotion, pricing, branding, competitive strategy, and portfolio management. Chapters include such features as: · An extensive literature review, including coverage of research from fields other than marketing · an overview of how practitioners have addressed the topic · introduction of relevant analytical tools, such as statistics and ethnographic studies · suggestions for further research by scholars and students The result is a comprehensive, state-of-the-art resource that will be of interest to researchers, policymakers, and practitioners, alike.

The Oxford Handbook Of The Economics Of The Biopharmaceutical Industry

Author: Patricia M. Danzon
Publisher: Oxford University Press
ISBN: 0199909261
Size: 61.81 MB
Format: PDF
View: 5987
Download and Read
The biopharmaceutical industry has been a major driver of technological change in health care, producing unprecedented benefits for patients, cost challenges for payers, and profits for shareholders. As consumers and companies benefit from access to new drugs, policymakers around the globe seek mechanisms to control prices and expenditures commensurate with value. More recently the 1990s productivity boom of new products has turned into a productivity bust, with fewer and more modest innovations, and flat or declining revenues for innovative firms as generics replace their former blockbuster products. This timely volume examines the economics of the biopharmaceutical industry, with eighteen chapters by leading academic health economists. Part one examines the economics of biopharmaceutical innovation including determinants of the costs and returns to new drug development; how capital markets finance R&D and how costs of financing the biopharmaceutical industry compare to financing costs for other industries; the effects of safety and efficacy regulation by the Food and Drug Administration (FDA) and of price and reimbursement regulation on incentives for innovation; and the role of patents and regulatory exclusivities. Part two examines the market for biopharmaceuticals with chapters on prices and reimbursement in the US, the EU, and other industrialized countries, and in developing countries. It looks at the optimal design of insurance for drugs and the effects of cost sharing on spending and on health outcomes; how to measure the value of pharmaceuticals using pharmacoeconomics, including theory, practical challenges, and policy issues; how to measure pharmaceutical price growth over time and recent evidence; empirical evidence on the value of pharmaceuticals in terms of health outcomes; promotion of pharmaceuticals to physicians and consumers; the economics of vaccines; and a review of the evidence on effects of mergers, acquisitions and alliances. Each chapter summarizes the latest insights from theory and recent empirical evidence, and outlines important unanswered questions and areas for future research. Based on solid economics, it is nevertheless written in terms accessible to the general reader. The book is thus recommended reading for academic economists and non-economists, and for those in industry and policy who wish to understand the economics of this fascinating industry.

Modeling Markets

Author: Peter Leeflang
Publisher: Springer
ISBN: 1493920863
Size: 41.39 MB
Format: PDF, ePub
View: 3897
Download and Read
This book is about how models can be developed to represent demand and supply on markets, where the emphasis is on demand models. Its primary focus is on models that can be used by managers to support marketing decisions. The market environment is changing rapidly and constantly. Prior to the introduction of scanner equipment in retail outlets, ACNielsen, the major supplier of information on brand performance, claimed that its business was to provide the score but not to explain or predict it. With technological advances and the introduction of the Internet, the opportunity to obtain meaningful estimates of demand functions has vastly improved; models that provide information about the sensitivity of market behavior to marketing activities such as advertising, pricing, promotions and distribution are now routinely used by managers for the identification of changes in marketing programs that can improve brand performance. In today’s environment of information overload, the challenge is to make sense of the data that is being provided globally, in real time, from thousands of sources. Modeling Markets presents a comprehensive overview of the tools and methodologies that managers can use in decision making. It has long been known that even simple models outperform judgments in predicting outcomes in a wide variety of contexts. More complex models potentially provide insights about structural relations not available from casual observations. Although marketing models are now widely accepted, the quality of the marketing decisions is critically dependent upon the quality of the models on which those decisions are based. In this book, the authors present a wealth of insights developed at the forefront of the field, covering all key aspects of specification, estimation, validation and use of models. The most current insights and innovations in quantitative marketing are presented, including in-depth discussion of Bayesian estimation methods. Throughout the book, the authors provide examples and illustrations. This book will be of interest to researchers, analysts, managers and students who want to understand, develop or use models of marketing phenomena.

Pharmaceutical Marketing

Author: Eugene Mick Kolassa
Publisher: Informa Health Care
ISBN: 9780789015839
Size: 54.45 MB
Format: PDF
View: 3717
Download and Read
Explore the nuts and bolts of marketing pharmaceuticals today! Written by leading authorities in the field, Pharmaceutical Marketing: Principles, Environment, and Practice is the fifth in Dr. Mickey Smith's series of books on the subject which began in the 1960s. In this extraordinary book, he and his co-authors examine the principles of marketing pharmaceuticals, describe the environmental factors that affect their application, and show how these principles can be applied in response to those factors in practice. From the history and development of marketing pharmaceuticals to channel systems, legal requirements, budgeting, and product placement, this essential volume is a comprehensive text that will help students prepare for successful careers in this expanding field. From editor Mickey Smith: “Looking back on 40 years of experience, I’ve recently begun saying that most of the things I knew about pharmaceutical marketing over the years that made me so smart are not true anymore. But the fact is that the principles of marketing are as true as they were when they appeared in my first book (published in 1968). What has changed, and had to change, was the way the principles are applied. “This book is based on the premise that marketing follows certain principles and that pharmaceutical marketing is affected by a variety of environmental influences which lead to a rich array of marketing practices. These practices are presented to demonstrate how the successful application of marketing principles—with appropriate adaptation to environmental forces—can lead to success in the marketplace. Failures are also presented.” This well-referenced book explores and explains the principles and practical application of vital elements of pharmaceutical marketing, including: product pricing—with sections on trends, competition, reimbursement programs, public policy, and more research and development—including strategies relating to new products, product scope, positioning and repositioning, product elimination, diversification, and a fascinating case study about Ibuprofen promotion—rational and nonrational appeals, advertising prescription drugs to consumers, strategic choices among media types, budgeting, and more place factors, channel systems, physical distribution, and specialists and much more! Ideal for anyone entering or studying the pharmaceutical industry, Pharmaceutical Marketing: Principles, Environment, and Practice is a one-stop source of reliable knowledge that you’ll refer to again and again! In the editor's words, “Good marketing leads to good medicine. Exceptions exist, but when the system works, bad marketing never succeeds for long—and neither does bad medicine.”

Reconfiguring Global Health Innovation

Author: Padmashree Gehl Sampath
Publisher: Routledge
ISBN: 1136892966
Size: 30.84 MB
Format: PDF, Kindle
View: 1288
Download and Read
This book looks at the experiences of different latecomer countries in promoting sustainable health innovation systems to cater to local needs, presenting empirical findings from India, Bangladesh, Vietnam, Kenya, Tanzania and Nigeria.

A Practical Approach To Pharmaceutical Policy

Author: Andreas Seiter
Publisher: World Bank Publications
ISBN: 9780821383872
Size: 19.48 MB
Format: PDF, Kindle
View: 5340
Download and Read
This book offers policy makers a hands-on approach, tested in the World Bank’s field work in many countries, for developing policies that improve access to safe, effective medicines in health systems of low- and middle-income economies.

Brand Therapy

Author: Brian D Smith, BSC BSC BSC
Publisher: Practical Inspiration Publishing
ISBN: 9781788600057
Size: 12.26 MB
Format: PDF, ePub, Docs
View: 619
Download and Read
A 'how to' book for brand teams in the pharma and medtech sectors. It describes when and how to use a selection of strategic planning tools.

Innovation In The Pharmaceutical Industry

Author: Takuji Hara
Publisher: Edward Elgar Publishing
ISBN: 1843765667
Size: 35.67 MB
Format: PDF, ePub, Docs
View: 6828
Download and Read
"Addressing a number of practical implications for the promotion of the pharmaceutical industry, this book will be of enormous interest to students, researchers and academics specializing in science and technology studies, and the management of technology and innovation. Practitioners, managers, and policy planners within the pharmaceutical industry will also deem this book invaluable."--BOOK JACKET.

The Changing Economics Of Medical Technology

Author: Committee on Technological Innovation in Medicine
Publisher: National Academies Press
ISBN: 030904491X
Size: 45.68 MB
Format: PDF, ePub
View: 665
Download and Read
Americans praise medical technology for saving lives and improving health. Yet, new technology is often cited as a key factor in skyrocketing medical costs. This volume, second in the Medical Innovation at the Crossroads series, examines how economic incentives for innovation are changing and what that means for the future of health care. Up-to-date with a wide variety of examples and case studies, this book explores how payment, patent, and regulatory policies--as well as the involvement of numerous government agencies--affect the introduction and use of new pharmaceuticals, medical devices, and surgical procedures. The volume also includes detailed comparisons of policies and patterns of technological innovation in Western Europe and Japan. This fact-filled and practical book will be of interest to economists, policymakers, health administrators, health care practitioners, and the concerned public.